| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |